The PE Ratio as of November 2024 (TTM) for Aptose Biosciences Inc. (APTO) is -0.07

According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.07. This represents a change of -83.16% compared to the average of -0.42 of the last 4 quarters.

Aptose Biosciences Inc. (APTO) Historical PE Ratio (quarterly & annually)

How has APTO PE Ratio performed in the past?

The mean historical PE Ratio of Aptose Biosciences Inc. over the last ten years is -40.23. The current -0.07 PE Ratio has changed -82.60% with respect to the historical average. Over the past ten years (40 quarters), APTO's PE Ratio was at its highest in in the March 2023 quarter at -0.08. The PE Ratio was at its lowest in in the December 2019 quarter at -0.72.

Aptose Biosciences Inc. (APTO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aptose Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptose Biosciences Inc. (APTO) Average PE Ratio

How has APTO PE Ratio performed in the past?

The current PE Ratio of Aptose Biosciences Inc. (APTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aptose Biosciences Inc. (APTO) PE Ratio vs. Peers

How is APTO’s PE Ratio compared to its peers?

Aptose Biosciences Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (5.48), greater than Instil Bio, Inc. (-2.26), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Spero Therapeutics, Inc. (21.41), greater than Assembly Biosciences, Inc. (-2.34), greater than Fortress Biotech, Inc. (-0.62), greater than Mustang Bio, Inc. (-0.32), greater than Achilles Therapeutics plc (-0.64), greater than Fortress Biotech, Inc. (-0.62), greater than Gain Therapeutics, Inc. (-2.14), greater than TFF Pharmaceuticals, Inc. (-0.08), greater than aTyr Pharma, Inc. (-2.33), greater than IN8bio, Inc. (-0.47), greater than Lantern Pharma Inc. (-1.74), greater than Affimed N.V. (-0.54), greater than Leap Therapeutics, Inc. (-1.63), greater than Adaptimmune Therapeutics plc (-3.77), greater than Corvus Pharmaceuticals, Inc. (-10.50), greater than Longboard Pharmaceuticals, Inc. (-30.52), less than TRACON Pharmaceuticals, Inc. (0.02), greater than Oncternal Therapeutics, Inc. (-0.10), greater than Aeglea BioTherapeutics, Inc. (-0.20),

Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.